Amgen close to Onyx takeover, deal possible within week-sources
NEW YORK, Aug 7 (Reuters) - Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc after the cancer drugmaker's high stock price discouraged other companies from making a counter offer, according to three people familiar with the matter. Amgen, the world's largest bio
Read more